Showing results (141-150 of 279) with videos related to
Sort By:
Pageof 28
Plos One|January 24, 2013
Impact of genetic polymorphisms of SLC2A2, SLC2A5, and KHK on metabolic phenotypes in hypertensive individualsMyPhuong T Le, Maximilian T Lobmeyer, Marcus Campbell, et al.Plos One|September 19, 2019
Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriersPatrick N Cunningham, Zhiying Wang, Megan L Grove, et al.Journal of Magnetic Resonance Imaging : JMRI|January 26, 2010
Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocolsDiego R Martin, Saravanan K Krishnamoorthy, Bobby Kalb, et al.Kidney International|June 16, 2026
A pilot study of magnetic resonance fingerprinting and radiomics analysis in autosomal dominant polycystic kidney diseaseLinnea E Kremer, Madison E Kretzler, Christina J MacAskill, et al.Hypertension (Dallas, Tex. : 1979)|November 18, 2009
Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medicationsRhonda M Cooper-DeHoff, Sheron Wen, Amber L Beitelshees, et al.Journal of the American Society of Nephrology : JASN|May 18, 2026
Pregnancy and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney DiseaseStephanie Lapierre-Nguyen, Zhiying You, Berenice Gitomer, et al.American Heart Journal|March 3, 2009
Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) studyJulie A Johnson, Eric Boerwinkle, Issam Zineh, et al.The Journal of Biological Chemistry|October 5, 2012
Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigenRongjuan Mi, Lina Song, Yingchun Wang, et al.Kidney International Reports|May 14, 2023
OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKDRonald D Perrone, Dorothee Oberdhan, John Ouyang, et al.Plos One|March 29, 2013
Pharmacometabolomics reveals racial differences in response to atenolol treatmentWilliam R Wikoff, Reginald F Frye, Hongjie Zhu, et al.Pageof 28